Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short Course High Dose Primaquine for P. vivax
NCT02364583Phase 4Unknown
- Sponsor
- Papua New Guinea Institute of Medical Research
- Start
- Jun 2010
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of primaquine in Plasmodium vivax malaria, sponsored by Papua New Guinea Institute of Medical Research. Status: unknown.
02
Drugs
primaquine
03
Conditions
Plasmodium vivax malaria
Beyond the preview
Go deeper on NCT02364583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02364583.